Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract
BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.
Unlocking Bruker ( BRKR ) International Revenues: Trends, Surprises, and Prospects
Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Superconducting Wire Market is expected to generate a revenue of USD 2.4 Billion by 2032, Globally, at 9.2% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- The Global Superconducting Wire Market Size is projected to grow at a CAGR of 9.2% from 2026 to 2032, according to a new report published by Verified Market Research®.
These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 Results - Bruker ( NASDAQ:BRKR )
Bruker Corporation BRKR reported worse-than-expected second-quarter financial results and cut its FY25 guidance on Monday. Bruker reported quarterly earnings of 32 cents per share which missed the analyst consensus estimate of 44 cents per share.
Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - Bruker ( NASDAQ:BRKR )
Bruker Corporation BRKR is currently in the 17th phase of its 18-phase Adhishthana cycle on the weekly chart and signals point to potential trouble ahead. While several large financial institutions remain bullish, our analysis under the Adhishthana Principles suggests a far more cautious stance.
Bruker ( BRKR ) Misses Q2 Earnings Estimates
Bruker (BRKR) delivered earnings and revenue surprises of -3.03% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Bruker ( BRKR ) Q2 Revenue Slips 0.4%
Bruker ( NASDAQ:BRKR ) , a global provider of scientific instruments and analytical solutions, reported earnings for Q2 2025 on August 4, 2025. GAAP revenue was $797.4 million, below the analyst consensus estimate of $810.1 million.
Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
BRKR Stock Gains Following the Multi-System Advanced Packaging Order
Bruker ships and installs its 15th InSight WLI system as part of a 27-optical metrology unit order tied to AI chip packaging demand.
New Strong Sell Stocks for June 23rd
ARCC, BIDU and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on June 23 2025.
Here's How Much You'd Have If You Invested $1000 in Agilent Technologies a Decade Ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Bruker Stock Set to Gain From Acquisition of Austria's biocrates
BRKR strengthens its MS-based metabolomics platform with the biocrates deal, boosting investor sentiment.
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer
BRKR unveils the MOVE-T analyzer to boost quality and efficiency in the dairy industry, setting new standards for precision and reliability.
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Equinor ( NYSE:EQNR ) , Bruker ( NASDAQ:BRKR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Raghuram Selvaraju downgraded the rating for UroGen Pharma Ltd.
International Markets and Bruker ( BRKR ) : A Deep Dive for Investors
Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash
Bruker delivers better-than-expected earnings and revenues in the first quarter of 2025.
Bruker ( BRKR ) Surpasses Q1 Earnings and Revenue Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 2.17% and 0.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Bruker ( BRKR ) Q1 Earnings Expected to Decline
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth - Bruker ( NASDAQ:BRKR )
ST. LOUIS, April 23, 2025 ( GLOBE NEWSWIRE ) -- Solis Agrosciences, the trusted partner for high-quality AgTech research services, announced that it has hired Crystal Winkeler as Chief Business Officer.
Bruker Stock May Benefit Following Its Investment in Ridom GmbH
BRKR announces a new partnership with NGS bioinformatics solution provider Ridom GmbH.
Why Is Life Science Focused Bruker Stock Trading Higher On Friday? - Bruker ( NASDAQ:BRKR )
Q1 revenue estimated at $795-$800 million vs. $758.9 million consensus, marking 10-11% YoY growth. BEST segment sees high-teens organic revenue decline, while BSI grows mid-single digits. China's new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for ...
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
BRKR's latest innovation offers 1H NMR and a choice of 15 X-nuclei with just one click.
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up
BRKR's new 1.3 GHz high-resolution NMR system comes with a stable, standard-bore 54 mm superconducting magnet.
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030 - The Insight Partners
US & Canada, April 04, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Apr, 02, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Microbial Identification Methods Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity ...
Molecular Diagnostic for Infectious Diseases Market Size to Reach $17.61 Billion by 2030, Driven by Technological Advancements and Rising Global Disease Burden - The Insight Partners
US & Canada, April 04, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Apr, 02, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Molecular Diagnostic for Infectious Diseases Market Size and Forecast ( 2020 - 2030 ) , Global and Regional Share, Trend, and Growth ...
Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?
BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail
BRKR NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.
Blood Culture Tests Market Size is Projected to Reach USD 18.14 Billion by 2033, Growing at a CAGR of 12.1%: Straits Research
New York, United States, March 06, 2025 ( GLOBE NEWSWIRE ) -- The presence of microorganisms in the blood, such as bacteria, yeast, and other types of microorganisms, can be determined by performing a blood culture on the patient.
Scanning Electron Microscope Market Size is Expected to Reach USD 9.58 Billion by 2033, Growing at a CAGR of 8.4%: Straits Research
New York, United States, March 06, 2025 ( GLOBE NEWSWIRE ) -- Electron microscopy is a method for obtaining high-resolution images of biological and non-biological specimens. It is widely employed in biomedical research to investigate the intricate structure of tissues, cells, organelles, and ...
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM
BRKR unveils X4 POSEIDON advanced XRM for 3D microscopy in industrial and scientific applications.
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.
Bruker ( BRKR ) Q4 Earnings and Revenues Surpass Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 1.33% and 0.91%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Bruker ( BRKR ) to Report Q4 Results: Wall Street Expects Earnings Growth
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CALID Arm Growth to Support Bruker Shares Amid Macro Issues
BRKR's NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.
BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope
Bruker launches LUMOS II ILIM QCL-based IR microscope for pharma and life science research.
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs
Bruker announces a 1.2 GHz NMR spectrometer at the Swiss High-field NMR facility.
PET/CT System Market is Projected to Reach US$ 5.27 Billion, Growing at 6.1% CAGR by 2034 | Fact.MR Report
Rockville, MD, Dec. 16, 2024 ( GLOBE NEWSWIRE ) -- The global PET/CT system market is projected to reach US$ 5.27 billion by the end of 2034, up from US$ 2.92 billion in 2024, according to the latest industry analysis by Fact.MR. Continuous technical advancements in PET/CT systems are improving ...
Why Is Bruker ( BRKR ) Up 0.9% Since Last Earnings Report?
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - ConocoPhillips ( NYSE:COP ) , Bruker ( NASDAQ:BRKR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan analyst Arun Jayaram upgraded ConocoPhillips COP from Neutral to Overweight and raised the price ...
IonOpticks' Custom Chromatography Column to Become Biognosys' Standard for High-Quality Proteomic Insights
MELBOURNE, Australia and ZURICH, Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement.
Bruker Stock Might Rise From the Launch of Dimension Nexus AFM
BRKR launches the Dimension Nexus AFM at the 2024 MRS Fall Meeting & Exhibit, expanding its Dimension AFM product line.
Sample Preparation Market is Poised to Register CAGR of 6.4% by 2031 | SkyQuest Technology
Westford, USA, Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Sample Preparation Market share will reach a value of USD 11446.67 Million by 2031, with a CAGR of 6.4% during the forecast period ( 2024-2031 ) .
New Strong Sell Stocks for November 21st
BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024.
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday - Azenta ( NASDAQ:AZTA ) , Alignment Healthcare ( NASDAQ:ALHC )
U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday. Shares of Williams-Sonoma, Inc. WSM rose sharply during Wednesday's session after the company reported better-than-expected third-quarter financial results.
Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development - Dragonfly Energy Hldgs ( NASDAQ:DFLI ) , Bruker ( NASDAQ:BRKR )
This strategic partnership leverages the complementary strengths of Dragonfly Energy and Bruker, bringing Dragonfly Energy's thorough expertise in liquid and solid-state battery technology together with Bruker's comprehensive suite of analytical solutions for battery research, development and ...
New Strong Sell Stocks for November 12th
BRKR, CMC and CNXC have been added to the Zacks Rank #5 (Strong Sell) List on November 12, 2024.
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
Bruker's new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform.
BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket
Bruker delivers robust revenue growth in the third quarter despite soft general market conditions.
Bruker Analysts Cut Their Forecasts After Q3 Results - Bruker ( NASDAQ:BRKR )
Bruker Corporation BRKR posted better-than-expected third-quarter results, but lowered its FY24 guidance on Tuesday. Bruker posted adjusted earnings of 60 cents per share, beating market estimates of 59 cents per share. The company posted sales of $864.400 million versus expectations of $859.384 ...
Bruker ( BRKR ) Q3 Earnings and Revenues Lag Estimates
Bruker (BRKR) delivered earnings and revenue surprises of -1.64% and 0.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
